RxDoctor Payments Data

Ricky Isernhagen, MD

Retina Specialist · Lexington, KYNPI 1700881919

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,000 of the $5,139 with a category attached, or 77.8%. Carl Zeiss Meditec, Inc. accounts for 77.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $4,353 and has fallen 99.6% since, to $16 in 2025.

$5,139in general payments, 2019–2025

Across 24 payments — averaging $214.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec, Inc.$4K
  • AbbVie$358
  • Optos, Inc.$354
  • Genentech USA, Inc.$306
  • Regeneron Healthcare Solutions, Inc.$49
  • Novartis$31
  • plus $40 from 2 others
$141,750in research payments, 2019–2025

Across 25 payments — averaging $5670.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$81K
  • Apellis Pharmaceuticals, Inc.$60K

What the payments were for

  • Consulting fees$4,00078%
  • Food & beverage$1,13922%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,139 in reported general payments places this provider in the 60th percentile of 22 retina specialist providers in Kentucky.

See all retina specialist providers in Kentucky

Medicare billing

Part B allowed, 2024
$176,851
Medicare patients
104
Services billed
1,257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other retina specialist in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →